These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21435750)

  • 1. [Spanish translation and validation of an Executive Battery 25 (EB25) and its shortened version (ABE12) for executive dysfunction screening in dementia].
    Serrani Azcurra DJ
    Neurologia; 2013 Oct; 28(8):457-76. PubMed ID: 21435750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test Your Memory-Spanish version (TYM-S): a validation study of a self-administered cognitive screening test.
    Muñoz-Neira C; Henríquez Chaparro F; Delgado C; Brown J; Slachevsky A
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):730-40. PubMed ID: 24390843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DEX and executive dysfunction in activities of daily living in Alzheimer's disease and frontotemporal dementia].
    Piquard A; Derouesné C; Meininger V; Lacomblez L
    Psychol Neuropsychiatr Vieil; 2010 Sep; 8(3):215-24; quiz 225-7. PubMed ID: 20739260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
    Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
    Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Spanish version of the Addenbrooke's Cognitive Examination in a rural community in Spain.
    García-Caballero A; García-Lado I; González-Hermida J; Recimil M; Area R; Manes F; Lamas S; Berrios G
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):239-45. PubMed ID: 16477583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neuropsychological battery to detect specific executive and social cognitive impairments in early frontotemporal dementia.
    Torralva T; Roca M; Gleichgerrcht E; Bekinschtein T; Manes F
    Brain; 2009 May; 132(Pt 5):1299-309. PubMed ID: 19336463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the clinical usefulness of the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS) and the Frontal Assessment Battery (FAB) in frontotemporal dementia.
    Gleichgerrcht E; Roca M; Manes F; Torralva T
    J Clin Exp Neuropsychol; 2011 Nov; 33(9):997-1004. PubMed ID: 21923634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Spanish Version of the Addenbrooke's Cognitive Examination-Revised (ACE-R).
    Torralva T; Roca M; Gleichgerrcht E; Bonifacio A; Raimondi C; Manes F
    Neurologia; 2011; 26(6):351-6. PubMed ID: 21232827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The executive interview as a screening test for executive dysfunction in patients with mild dementia.
    Stokholm J; Vogel A; Gade A; Waldemar G
    J Am Geriatr Soc; 2005 Sep; 53(9):1577-81. PubMed ID: 16137290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Japanese version of the Frontal Assessment Battery in patients with the frontal variant of frontotemporal dementia.
    Nakaaki S; Murata Y; Sato J; Shinagawa Y; Matsui T; Tatsumi H; Furukawa TA
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):78-83. PubMed ID: 17239043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.
    Heidler-Gary J; Gottesman R; Newhart M; Chang S; Ken L; Hillis AE
    Dement Geriatr Cogn Disord; 2007; 23(3):184-93. PubMed ID: 17220629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRONTIER Executive Screen: a brief executive battery to differentiate frontotemporal dementia and Alzheimer's disease.
    Leslie FV; Foxe D; Daveson N; Flannagan E; Hodges JR; Piguet O
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):831-5. PubMed ID: 26420887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Spanish version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Matias-Guiu JA; Fernández de Bobadilla R; Escudero G; Pérez-Pérez J; Cortés A; Morenas-Rodríguez E; Valles-Salgado M; Moreno-Ramos T; Kulisevsky J; Matías-Guiu J
    Neurologia; 2015; 30(9):545-51. PubMed ID: 25002342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Frontal Assessment Battery (FAB): normative data from an Italian sample and performances of patients with Alzheimer's disease and frontotemporal dementia.
    Iavarone A; Ronga B; Pellegrino L; Loré E; Vitaliano S; Galeone F; Carlomagno S
    Funct Neurol; 2004; 19(3):191-5. PubMed ID: 15595714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frontal assessment battery in the differential diagnosis of dementia.
    Boban M; Malojcić B; Mimica N; Vuković S; Zrilić I
    J Geriatr Psychiatry Neurol; 2012 Dec; 25(4):201-7. PubMed ID: 23172762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining Executive Dysfunction with the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS): normative values from a healthy sample and clinical utility in Alzheimer's disease.
    Moreira HS; Lima CF; Vicente SG
    J Alzheimers Dis; 2014; 42(1):261-73. PubMed ID: 24840570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.